1. Yan, Hai, Parsons, D Williams, Jin, Genglin, Vogelstein, Bert, Bigner, Darell D. . IDH1 and IDH2 mutations in gliomas. In The New England journal of medicine, 360, 765-73. doi:10.1056/NEJMoa0808710. https://pubmed.ncbi.nlm.nih.gov/19228619/
2. Kim, Jee In, Noh, Mi Ra, Yoon, Ga-Eun, Kong, Min Jung, Park, Kwon Moo. . IDH2 gene deficiency accelerates unilateral ureteral obstruction-induced kidney inflammation through oxidative stress and activation of macrophages. In The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 25, 139-146. doi:10.4196/kjpp.2021.25.2.139. https://pubmed.ncbi.nlm.nih.gov/33602884/
3. Babakhanlou, Rodrick, DiNardo, Courtney, Borthakur, Gautam. 2023. IDH2 mutations in acute myeloid leukemia. In Leukemia & lymphoma, 64, 1733-1741. doi:10.1080/10428194.2023.2237153. https://pubmed.ncbi.nlm.nih.gov/37462435/
4. Figueroa, Maria E, Abdel-Wahab, Omar, Lu, Chao, Levine, Ross L, Melnick, Ari. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. In Cancer cell, 18, 553-67. doi:10.1016/j.ccr.2010.11.015. https://pubmed.ncbi.nlm.nih.gov/21130701/
5. Yoshimi, Akihide, Lin, Kuan-Ting, Wiseman, Daniel H, Krainer, Adrian R, Abdel-Wahab, Omar. 2019. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. In Nature, 574, 273-277. doi:10.1038/s41586-019-1618-0. https://pubmed.ncbi.nlm.nih.gov/31578525/
智鼠故事 
